Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.38M
2.50K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 2.50K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/21/2026ACC: 0001628280-26-048913
DirectorOfficer· President and CEO
Since Mar 2026
2.50K
Shares to sell
$1.38M
Approx. market value
2.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Grant
Vesting of Performance Restricted Stock Units
7/17/2026
2.50KTotal acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/17/2026 | Performance Restricted Stock Unit Grant Vesting of Performance Restricted Stock Units | 2.50K | — |
| Total | 2.50K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
2.50K
Market value
$1.38M
7/20/2026
Total
Units
2.50K
Value
$1.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/20/2026 | 2.50K | $1.38M | Nasdaq Stock Market | Planned |
| Total | 2.50K | $1.38M | ||